A North Wales cancer patient has become the first in the world to take part in a new trial looking for a more effective treatment for myeloma. The...
Day: 14 August 2018
NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients
A multidisciplinary team of researchers from the National University of Singapore (NUS) has developed an artificial intelligence (AI) technology...
Bortezomib-Based Therapy Effective for Relapsed/Refractory Myeloma
A group of “real-world” patients with relapsed or refractory multiple myeloma had high response rates and an overall survival (OS) of about 3 years...